Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NeoSculpt Plus

K-Number: K252888 · 2026-03-09

Decision Date2026-03-09
Product CodePBX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

NeoSculpt Plus is a medical device manufactured by S&M Medical Co., Ltd.. It received FDA 510(k) clearance on 2026-03-09 under approval number K252888. The device is classified under product code PBX. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NeoSculpt Plus?

NeoSculpt Plus is a medical device that received FDA 510(k) clearance on 2026-03-09. It is manufactured by S&M Medical Co., Ltd.. The 510(k) number is K252888.

When was NeoSculpt Plus approved by the FDA?

NeoSculpt Plus received FDA 510(k) clearance on 2026-03-09, under approval number K252888.

What company makes NeoSculpt Plus?

NeoSculpt Plus is manufactured by S&M Medical Co., Ltd..

What is the FDA product code for NeoSculpt Plus?

The FDA product code for NeoSculpt Plus is PBX.

Related Devices (Code: PBX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.